NCT05716659View on ClinicalTrials.gov

EEG/MECG/EMG Evaluating the Severity of Aortic Stenosis, Heart Failure and Ischemic Stroke Through an Artificial Intelligenceassisted System.

Not yet recruitingOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

July 31, 2032

Study Completion Date

August 31, 2032

Conditions
CVD
Trial Locations (1)

Unknown

NTUH, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT05716659 - EEG/MECG/EMG Evaluating the Severity of Aortic Stenosis, Heart Failure and Ischemic Stroke Through an Artificial Intelligenceassisted System. | Biotech Hunter | Biotech Hunter